British GlaxoSmithKline To Complete Acquisition Of Chinese Meirui For $70 Million By Year's End
This article was originally published in PharmAsia News
Executive Summary
British pharmaceutical giant GlaxoSmithKline recently announced its acquisition of Chinese drugmaker Nanjing MeiRui Pharma for $700 million, and expects to complete the transaction by year's end